Category - Pharma Industry News
AZ’s long-acting COVID-19 antibody fails to meet primary endpoint in prevention trial
Biogen’s inherited eye disease gene therapy misses the mark in late-stage trial
Imbruvica/Venclyxto tops Gazyva plus chemo in first-line CLL/SLL
AZ, Pfizer/BioNTech vaccines ‘highly effective’ against Delta variant
Novavax’s COVID-19 vaccine shows 90% efficacy in Phase III
Novartis’ iptacopan scores positive results in rare blood disorder PNH
A starting roadmap to reshoring pharma
Sanofi’s C1s inhibitor sutimlimab hits the mark in late-stage CAD study